Skip to main content

Advertisement

SpringerLink
Log in

STEPP for the EGFR Inhibitor–Induced Rash—Definitely a Step in the Right Direction

  • Clinical Trial Report
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Solomon BM, Jatoi A: Rash from EGFR inhibitors: opportunities and challenges for palliation. Curr Oncol Rep 2008, 10:304–308.

    Article  CAS  PubMed  Google Scholar 

  2. Wagner LI, Lacouture ME: Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist’s perspective. Oncology 2007, 21:34–36.

    PubMed  Google Scholar 

  3. Scope A, Agero AL, Dusza SW, et al.: Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. J Clin Oncol 2007, 25:5390–5396.

    Article  CAS  PubMed  Google Scholar 

  4. Jatoi A, Rowland K, Sloan JA, et al.: Tetracycline to prevent epidermal growth factor receptor inhibitor-induced rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Cancer 2008, 113:847–853.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by 5K24CA131099 and R21CA134432.

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Shawnta Coleman & Aminah Jatoi

Authors
  1. Shawnta Coleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aminah Jatoi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aminah Jatoi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coleman, S., Jatoi, A. STEPP for the EGFR Inhibitor–Induced Rash—Definitely a Step in the Right Direction. Curr Oncol Rep 12, 223–225 (2010). https://doi.org/10.1007/s11912-010-0102-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-010-0102-7

Keywords

Search

Navigation